|
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
|
№16 / 2012
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
T.V. Nikonova
Sustained-release Metformin (glucophage Long) In The Management Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
Ye.V. Biryukova (1), M.B. Antsiferov (2)
How To Effectively Manage Two Major Defects In Type 2 Diabetes Mellitus?
|
№3 / 2012
|
|
E. Doskina
Diabetic Polyneuropathy And Vitamin B12-deficiency States: Pathogenesis, Treatment And Prevention
|
№20 / 2011
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
|
M.B. Antciferov
Dipeptidyl Peptidase-4 Inhibitors - New Potentials For Treatment Of Type 2 Diabetes Mellitus: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№16 / 2011
|
|
A.M. Shilov, A.O. Osia, M.S. Dulayeva, I.V. Yeremina
Pathophysiological Features Of Treatment Of Arterial Hypertension And Disorders Of Carbohydrate Metabolism
|
№5 / 2011
|
|
Anciferov M.B.
Clinical Aspects For Use Of Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Benefits For Different Groups Of Patients
|
№3 / 2011
|
|
Petunina N.A., Truhina L.V.
Combined Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2011
|
|
M.B. Antsiferov, L.Yu. Morgunov, N.A. Demidov, I.V. Volokitin
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
|
N.A. Petunina
When To Begin Combined Therapy Of Type 2 Diabetes Mellitus
|
№16 / 2010
|
Русский
